Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Viscosupplementation Market, by Application
1.4.2 Europe Viscosupplementation Market, by Product
1.4.3 Europe Viscosupplementation Market, by End-use
1.4.4 Europe Viscosupplementation Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Viscosupplementation Market by Application
4.1 Europe Knee Osteoarthritis Market by Country
4.2 Europe Hand Osteoarthritis Market by Country
4.3 Europe Hip Osteoarthritis Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Viscosupplementation Market by Product
5.1 Europe Three Injection Market by Country
5.2 Europe Single Injection Market by Country
5.3 Europe Five Injection Market by Country
Chapter 6. Europe Viscosupplementation Market by End-use
6.1 Europe Hospitals Market by Country
6.2 Europe Orthopedic Clinics/ASCs Market by Country
Chapter 7. Europe Viscosupplementation Market by Country
7.1 Germany Viscosupplementation Market
7.1.1 Germany Viscosupplementation Market by Application
7.1.2 Germany Viscosupplementation Market by Product
7.1.3 Germany Viscosupplementation Market by End-use
7.2 UK Viscosupplementation Market
7.2.1 UK Viscosupplementation Market by Application
7.2.2 UK Viscosupplementation Market by Product
7.2.3 UK Viscosupplementation Market by End-use
7.3 France Viscosupplementation Market
7.3.1 France Viscosupplementation Market by Application
7.3.2 France Viscosupplementation Market by Product
7.3.3 France Viscosupplementation Market by End-use
7.4 Russia Viscosupplementation Market
7.4.1 Russia Viscosupplementation Market by Application
7.4.2 Russia Viscosupplementation Market by Product
7.4.3 Russia Viscosupplementation Market by End-use
7.5 Spain Viscosupplementation Market
7.5.1 Spain Viscosupplementation Market by Application
7.5.2 Spain Viscosupplementation Market by Product
7.5.3 Spain Viscosupplementation Market by End-use
7.6 Italy Viscosupplementation Market
7.6.1 Italy Viscosupplementation Market by Application
7.6.2 Italy Viscosupplementation Market by Product
7.6.3 Italy Viscosupplementation Market by End-use
7.7 Rest of Europe Viscosupplementation Market
7.7.1 Rest of Europe Viscosupplementation Market by Application
7.7.2 Rest of Europe Viscosupplementation Market by Product
7.7.3 Rest of Europe Viscosupplementation Market by End-use
Chapter 8. Company Profiles
8.1 DePuy Synthes (Johnson & Johnson)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Ferring Holdings SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 LG Chem Ltd. (LG Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 SWOT Analysis
8.7 Anika Therapeutics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Smith & Nephew PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional and Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Seikagaku Corp.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 